James R Broughman1, Grant R Williams2, Allison M Deal3, Hyeon Yu2, Kirsten A Nyrop2, Shani M Alston3, Brittaney-Belle Gordon2, Hanna K Sanoff2, Hyman B Muss2. 1. School of Medicine, University of North Carolina at Chapel Hill, 321 S Columbia St., Chapel Hill, NC 27516, United States. Electronic address: james_broughman@med.unc.edu. 2. School of Medicine, University of North Carolina at Chapel Hill, 321 S Columbia St., Chapel Hill, NC 27516, United States; UNC Lineberger Comprehensive Cancer Center, 101 Manning Dr., Chapel Hill, NC 27514, United States. 3. UNC Lineberger Comprehensive Cancer Center, 101 Manning Dr., Chapel Hill, NC 27514, United States.
Abstract
OBJECTIVE: Sarcopenia is the age-related loss of muscle mass, strength, and function. It is a common finding in older patients and is associated with decreased life expectancy and potentially higher susceptibility to chemotherapy toxicity. This study describes the prevalence of sarcopenia in older adults with early stage colorectal cancer. MATERIALS AND METHODS: Patients ≥70 years old who underwent surgical resection for stage I-III colorectal cancer between 2008 and 2013 were identified from the medical record. Sarcopenia was assessed by measuring the total muscle area on computerized tomography (CT) images obtained prior to surgery. Total muscle area was measured at the level of L3 and normalized using each patient's height to produce a skeletal muscle index (SMI). Sarcopenia was defined using sex- and body mass index (BMI)-specific threshold values of SMI. RESULTS: Eighty-seven patients were included, with a median age of 77 years (70-96). Twenty-five men (60% of 42) and 25 women (56% of 45) had sarcopenia. Sarcopenic patients had significantly lower BMI (p=0.03) compared to non-sarcopenic patients. There was a positive correlation between BMI and SMI for both men (r=0.44) and women (r=0.16). CONCLUSION: Sarcopenia is highly prevalent among older patients with early stage colorectal cancer. BMI alone is a poor indicator of lean body mass and improved methods of screening for sarcopenia are necessary. CT scans are a viable option for identifying sarcopenic patients in whom timely interventions may improve survival, quality of life, and functional outcomes.
OBJECTIVE:Sarcopenia is the age-related loss of muscle mass, strength, and function. It is a common finding in older patients and is associated with decreased life expectancy and potentially higher susceptibility to chemotherapy toxicity. This study describes the prevalence of sarcopenia in older adults with early stage colorectal cancer. MATERIALS AND METHODS:Patients ≥70 years old who underwent surgical resection for stage I-III colorectal cancer between 2008 and 2013 were identified from the medical record. Sarcopenia was assessed by measuring the total muscle area on computerized tomography (CT) images obtained prior to surgery. Total muscle area was measured at the level of L3 and normalized using each patient's height to produce a skeletal muscle index (SMI). Sarcopenia was defined using sex- and body mass index (BMI)-specific threshold values of SMI. RESULTS: Eighty-seven patients were included, with a median age of 77 years (70-96). Twenty-five men (60% of 42) and 25 women (56% of 45) had sarcopenia. Sarcopenic patients had significantly lower BMI (p=0.03) compared to non-sarcopenicpatients. There was a positive correlation between BMI and SMI for both men (r=0.44) and women (r=0.16). CONCLUSION:Sarcopenia is highly prevalent among older patients with early stage colorectal cancer. BMI alone is a poor indicator of lean body mass and improved methods of screening for sarcopenia are necessary. CT scans are a viable option for identifying sarcopenic patients in whom timely interventions may improve survival, quality of life, and functional outcomes.
Authors: Ki-Yong Ahn; Hyuk Hur; Dong-Hyun Kim; Jihee Min; Duck Hyoun Jeong; Sang Hui Chu; Ji Won Lee; Jennifer A Ligibel; Jeffrey A Meyerhardt; Lee W Jones; Justin Y Jeon; Nam Kyu Kim Journal: Int J Colorectal Dis Date: 2013-02-17 Impact factor: 2.571
Authors: Martin A Makary; Dorry L Segev; Peter J Pronovost; Dora Syin; Karen Bandeen-Roche; Purvi Patel; Ryan Takenaga; Lara Devgan; Christine G Holzmueller; Jing Tian; Linda P Fried Journal: J Am Coll Surg Date: 2010-04-28 Impact factor: 6.113
Authors: Francesco Landi; Alfonso J Cruz-Jentoft; Rosa Liperoti; Andrea Russo; Silvia Giovannini; Matteo Tosato; Ettore Capoluongo; Roberto Bernabei; Graziano Onder Journal: Age Ageing Date: 2013-01-15 Impact factor: 10.668
Authors: Lisa Martin; Laura Birdsell; Neil Macdonald; Tony Reiman; M Thomas Clandinin; Linda J McCargar; Rachel Murphy; Sunita Ghosh; Michael B Sawyer; Vickie E Baracos Journal: J Clin Oncol Date: 2013-03-25 Impact factor: 44.544
Authors: Chelsia Gillis; Chao Li; Lawrence Lee; Rashami Awasthi; Berson Augustin; Ann Gamsa; A Sender Liberman; Barry Stein; Patrick Charlebois; Liane S Feldman; Francesco Carli Journal: Anesthesiology Date: 2014-11 Impact factor: 7.892
Authors: Grant R Williams; Allison M Deal; Hyman B Muss; Marc S Weinberg; Hanna K Sanoff; Emily J Guerard; Kirsten A Nyrop; Mackenzi Pergolotti; Shlomit Strulov Shachar Journal: J Geriatr Oncol Date: 2017-08-24 Impact factor: 3.599
Authors: Utku Oflazoglu; Ahmet Alacacioglu; Umut Varol; Yuksel Kucukzeybek; Tarik Salman; Halil Taskaynatan; Yasar Yildiz; Ozlem Ozdemir; MustafaOktay Tarhan Journal: Support Care Cancer Date: 2019-06-03 Impact factor: 3.603
Authors: Grant R Williams; Allison M Deal; Shlomit Strulov Shachar; Christine M Walko; Jai N Patel; Bert O'Neil; Howard L McLeod; Marc S Weinberg; Seul Ki Choi; Hyman B Muss; Hanna K Sanoff Journal: Cancer Chemother Pharmacol Date: 2017-11-20 Impact factor: 3.333